Biden administration and Gilead settle long-running battle over patents for HIV PrEP pills

Taking stock of the drug industry, from the lab to the medicine chest

January 15, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Rich Pedroncelli/AP STAT+ | Biden administration and Gilead settle long-running battle over patents for HIV PrEP pills The Biden administration had sought $1 billion in royalties but had lost a jury decision in 2023 that ruled its patents were invalid. By Ed Silverman STAT+ | Eli Lilly CEO says the company sees 'significant common cause' with Trump administration Eli Lilly CEO, speaking from the sidelines of the JP Morgan Healthcare Conference, talks earnings, weight loss drugs, finding common cause with MAHA. By Matthew Herper and Elaine Chen STAT+ | International monitor recommends end to some monkey shipments from Cambodia The move "should put an end to the exploitation of these monkeys by international profiteers exploiting these endangered animals," said PETA. By Ed Silverman Kevin Frayer/Getty Images STAT+ | At JPM, biotech industry expresses excitement — and some anxiety — about therapies from China As American venture capital rushes to cash in on Chinese biotech deals, execs worry about China's rapid growth: "Folks there are good at moving quickly." By Allison DeAngelis Eli Lilly is considering offering more Zepbound doses in vials at lower cost Zepbound, and its sister diabetes drug Mounjaro, are among the new GLP-1 medications that have revolutionized the treatment of obesity. By Elaine Chen Opinion: Will PBM reform save pharmacies from closing? Some policymakers think PBM reform and divestment will save pharmacies, but it's not that simple. By T. Joseph Mattingly II and Kelly E. Anderson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser